A look at financing, M&A, and alliance activity April–June 2009 In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmaking—f
by Anne Staylor and Mary Thompson For device developers, the market for acute ischemic stroke (AIS) has been enticing as the lack of effective treatment options coupled with the huge unmet clinical ne